R&D CI Analyst's Right Hand.
December 20, 2022
R&D CI Analyst's Right Hand.
Score 10 out of 10
Vetted Review
Verified User
Overall Satisfaction with AlphaSense
I use it for support in building my competitive pipelines in neurology and rare diseases. It is great for updating clinical trials I am watching within 24 hours of a development -- a very important part of my job in alerting project teams about important developments that they would not see otherwise, and the analysts' comments after quarterly and investor meetings are important for getting an outside view of the projects' values. It also helps me track competitors that are in later stages than our internal projects, as I don't have market research sources. I have also just started using the Expert Calls module -- fantastic for seeing what R&D leaders and former R&D corporate people are saying about therapeutic areas and particular products.
- Clinical Trials updating FAST -- and coding the most important changes in the header (New trial, primary completion date changes, etc.)
- They are providing access to meeting presentations faster than they go up on the meeting or corporate websites. Plus it acts as an archive -- if the company is absorbed by another company, the old document is still there.
- Although I do not have to "crunch numbers," the selection of analyst reports with strong pharma science analysts helps me to put company press releases and presentations into a proper perspective.
- For news/press releases, the ability to specify that the search words are in the heading/title or first two paragraphs.
- More clinical trial registries -- adding Australia-New Zealand, Japan, and whatever the UK comes up with now that it is not part of the EU would be extremely helpful.
- More KOL calls in pharma/biotech -- yes, I'm greedy, but I am already finding them to be a great resource. Also adding some ex-US sources to get the European perspective.
- Better R&D CI.
- Timelier analyses, because so much updating is in real-time.
- Good monitoring capabilities with alerts.
Very aware - there are sometimes announcements of research program terminations that are NOT in press releases or business press and not in company presentations -- BUT REFERENCED IN THEIR EARNINGS CALLS!! Two times I was able to show my team that a project was terminated even though an "official" announcement was never made. On the R&D side, company news resources are often scarce/not available because of budgets (unlike on the commercial side). So, as an R&D CI person, having a quick update source for "buried news" is necessary.
Nothing like Alphasense -- and with the demise of many companies' RSS feeds, AlphaSense becomes even more important. The only other sources I use are pipeline databases and clinical trials databases (where hypothetical trials get listed) -- so there is no competition for the speed with which AlphaSense updates.
Do you think AlphaSense delivers good value for the price?
Yes
Are you happy with AlphaSense's feature set?
Yes
Did AlphaSense live up to sales and marketing promises?
Yes
Did implementation of AlphaSense go as expected?
Yes
Would you buy AlphaSense again?
Yes